Mark Crockett, MDMolecular ImagingTargeted radiopharmaceuticals offer new hope for longer 'healthspans'Precision radiopharmaceuticals accurately target tumors while minimizing damage to healthy tissue, presenting an opportunity to extend not just lifespans but “healthspans,” Mark Crockett, MD, explains in this article.March 15, 2024Page 1 of 1Top StoriesCTWhat causes lung cancers to be missed on screening?Incomplete smoking history documentation appears to be one of the reasons.Molecular ImagingEarly PET/CT feasible in women with suspected breast cancerWomens ImagingStudy highlights risk-based breast cancer screening; ACR respondsAIIs AI ready for autonomous reads of chest x-rays?AIPatients support AI in radiology, but not as a standalone reader
